(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 18.54% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Hyperfine's revenue in 2025 is $11,732,000.On average, 1 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,049,281,178, with the lowest HYPR revenue forecast at $1,049,281,178, and the highest HYPR revenue forecast at $1,049,281,178. On average, 1 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,305,374,285, with the lowest HYPR revenue forecast at $1,305,374,285, and the highest HYPR revenue forecast at $1,305,374,285.
In 2027, HYPR is forecast to generate $1,495,303,519 in revenue, with the lowest revenue forecast at $1,495,303,519 and the highest revenue forecast at $1,495,303,519.